MARKET

RVMD

RVMD

Revolution Medicines, Inc.
NASDAQ
42.00
+0.55
+1.33%
After Hours: 43.22 +1.22 +2.90% 19:08 02/12 EST
OPEN
40.73
PREV CLOSE
41.45
HIGH
42.10
LOW
40.73
VOLUME
1.04M
TURNOVER
--
52 WEEK HIGH
62.40
52 WEEK LOW
28.43
MARKET CAP
7.74B
P/E (TTM)
-11.7011
1D
5D
1M
3M
1Y
5Y
1D
Does Revolution Medicines (RVMD) Have the Potential to Rally 74.05% as Wall Street Analysts Expect?
NASDAQ · 2d ago
Weekly Report: what happened at RVMD last week (0203-0207)?
Weekly Report · 3d ago
Are Investors Undervaluing Revolution Medicines, Inc. (NASDAQ:RVMD) By 49%?
Simply Wall St · 02/03 10:10
Weekly Report: what happened at RVMD last week (0127-0131)?
Weekly Report · 02/03 09:14
Sum Up The Parts: JHMM Could Be Worth $70
NASDAQ · 01/30 12:31
Revolution Medicines: New Data Underscore A True Cancer Revolution (Upgrade)
Seeking Alpha · 01/28 08:06
Weekly Report: what happened at RVMD last week (0120-0124)?
Weekly Report · 01/27 09:15
Keros Therapeutics (KROS) Soars 5.1%: Is Further Upside Left in the Stock?
NASDAQ · 01/22 13:53
More
About RVMD
Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. Its RAS Companion Inhibitors are designed primarily for combination treatment strategies centered on its RAS(ON) Inhibitors. The Company’s RAS(ON) Inhibitors RMC-6236 RMC-6291 and RMC-9805 are in clinical development. RMC-6236, its RASMULTI(ON) inhibitor, is designed as a potent, oral, RAS-selective tri-complex inhibitor of multiple RAS(ON) variants, including cancer drivers.

Webull offers Revolution Medicines Inc stock information, including NASDAQ: RVMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVMD stock methods without spending real money on the virtual paper trading platform.